CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study
Abroad (travel likely)RecruitingPHASE4
Conditions
Breast Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
UPMC Magee-Womens Hospital, Pittsburgh, Pennsylvania, United States
Study leads
Margarita L Zuley, MD
Principal Investigator
University of Pittsburgh